Hält derzeit eine Position bei TCR2 Therapeutics Inc
Position | Company | Period |
---|---|---|
President, Chief Executive Officer, Director | TCR2 Therapeutics Inc | 1. Dezember 2018 - |
Chief Executive Officer, Director | TCR2 Therapeutics Inc | 1. Januar 2016 - 1. Dezember 2018 |
Executive Vice President, Chief Business and Strategy Officer | Axcella Health Inc | 1. Oktober 2015 - 1. Januar 2018 |
Chief Financial Officer | DaVita Inc | 1. November 2013 - 30. März 2015 |
Chief Operating Officer, Executive Vice President - Finance | Regulus Therapeutics Inc | 2. Januar 2009 - 21. Juni 2013 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2023-07-10 | 2023-07-10 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
47.702
-38.9%
0,9143.447 USD |
47.702 -38.9% | 0,91 | 43.447 USD | |
2022-12-13 | 2022-12-13 |
TCR2 Therapeutics Inc
(TCRR)
|
GV Geplanter Verkauf |
11.000
-7.3%
1,0611.682 USD |
11.000 -7.3% | 1,06 | 11.682 USD | |
2022-12-13 | 2022-12-12 |
TCR2 Therapeutics Inc
(TCRR)
|
GV Geplanter Verkauf |
10.613
-6.6%
1,1011.674 USD |
10.613 -6.6% | 1,10 | 11.674 USD | |
2022-12-13 | 2022-12-09 |
TCR2 Therapeutics Inc
(TCRR)
|
GV Geplanter Verkauf |
10.325
-6.0%
1,1311.678 USD |
10.325 -6.0% | 1,13 | 11.678 USD | |
2022-12-09 | 2022-12-08 |
TCR2 Therapeutics Inc
(TCRR)
|
GV Geplanter Verkauf |
9.314
-5.2%
1,2511.680 USD |
9.314 -5.2% | 1,25 | 11.680 USD | |
2022-12-09 | 2022-12-07 |
TCR2 Therapeutics Inc
(TCRR)
|
GV Geplanter Verkauf |
9.111
-4.8%
1,2811.680 USD |
9.111 -4.8% | 1,28 | 11.680 USD | |
2022-12-07 | 2022-12-06 |
TCR2 Therapeutics Inc
(TCRR)
|
GV Geplanter Verkauf |
14.886
-7.3%
1,3520.081 USD |
14.886 -7.3% | 1,35 | 20.081 USD | |
2022-12-07 | 2022-12-05 |
TCR2 Therapeutics Inc
(TCRR)
|
GV Geplanter Verkauf |
8.530
-4.0%
1,3711.703 USD |
8.530 -4.0% | 1,37 | 11.703 USD | |
2022-12-05 | 2022-12-02 |
TCR2 Therapeutics Inc
(TCRR)
|
GV Geplanter Verkauf |
8.408
-3.8%
1,3911.687 USD |
8.408 -3.8% | 1,39 | 11.687 USD |